Table 3.
PSM test results
| Subjects | Total points PSM Test |
PPD n. of subjects (%) |
Wilcoxon Test |
|---|---|---|---|
| Group A (n. 688) (t0) | 122.53 ± 6.747 | n. 512 | Asymp. Sig. (2-tailed) 0.000 |
|
Group A (t1) |
96.01 ± 8.520 | n. 138 (20% of 512) | Z=-22.735 P < 0.005 |
| Group B (n. 200) (t0) | 122.96 ± 7.041 | n. 150 | Asymp. Sig. (2-tailed) 0.361 |
|
Group B (t1) |
122.11 ± 7.450 | n. 148 (98.6% of 150) | Z=-0.914 P > 0.005 |
Table legend text. PSM test results: Total points and Wilcoxon test results obtained in group A and in group B, before (t0) and after (t1) NPPO REAC treatment/placebo. Values of Total points are expressed by means ± Standard Deviation. *P < 0.05.